• Corpus ID: 45010813

Heart failure and electrolyte disturbances.

  title={Heart failure and electrolyte disturbances.},
  author={Robert H. G. Schwinger and Erland Erdmann},
  journal={Methods and findings in experimental and clinical pharmacology},
  volume={14 4},
  • R. SchwingerE. Erdmann
  • Published 1 May 1992
  • Medicine, Biology
  • Methods and findings in experimental and clinical pharmacology
Electrolyte abnormalities are a frequent and potentially hazardous complication in patients with heart failure. This may be due to the pathophysiological alterations seen in the heart failure state leading to neurohumoral activation (stimulation of the renin-angiotensin-aldosterone system, sympathoadrenergic stimulation), and due to the complications of therapy with diuretics, cardiac glycosides or ACE inhibitors. Patients with heart failure may exhibit hyponatremia due to a decrease in water… 

Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications

Electrolyte and acid–base abnormalities are a frequent and potentially dangerous complication in subjects with congestive heart failure and the early identification and the knowledge of the pathophysiological mechanisms are very useful for the management of these patients.

Hyperkalemia in Heart Failure.

Difficulties in maintaining potassium homeostasis in patients with heart failure

Avoiding both hypo‐ and hyperkalemia is beneficial in several cardiovascular diseases, especially heart failure, and Electrolyte abnormalities are frequently seen complications in subjects with heart failure.

Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration?

Oral Mg supplementation to HF patients significantly attenuates blood levels of CRP, a biomarker of inflammation, and targeting the inflammatory cascade by Mg administration might prove a useful tool for improving the prognosis in HF.

Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative

In post–myocardial infarction with systolic dysfunction and HF, low serum chloride was associated with mortality (but not hospitalization for HF) in the setting of lower sodium, and data support an integrated and critical consideration of chloride and sodium interplay.

Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions

Recent progress in management of hyponatraemia in SIADH, cirrhosis and heart failure is summarized.

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone

Risk factors for hyperkalemia are highlighted, including advanced chronic kidney disease, diabetes mellitus, cardiovascular disease, age, and use of renin-angiotensin-aldosterone system inhibitors, and approaches to prevention and management are examined, including potassium monitoring, diet, and the use of appropriate therapeutic techniques.

Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease

The possible mechanisms by which Mg deficiency plays detrimental roles in cardiovascular diseases is discussed and the results of clinical trials of Mg supplementation for heart failure, arrhythmias and other cardiovascular diseases are reviewed.